Patents by Inventor Daniel Edvardsson

Daniel Edvardsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms
    Publication number: 20060287249
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid slate stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: August 22, 2006
    Publication date: December 21, 2006
    Applicant: AstraZeneca AB
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • Crystalline forms
    Publication number: 20050153901
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: March 11, 2005
    Publication date: July 14, 2005
    Applicant: AstraZeneca AB
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • Crystalline forms of EtO2C-Ch2-(R)Cgi-Aze-Pab-OH
    Patent number: 6888007
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: May 3, 2005
    Assignee: AstraZeneca AB
    Inventors: Daniel Edvardsson, Lena Hedstróm, Anita Lundblad, Ursula Pettersson
  • NEW CRYSTALLINE FORMS
    Publication number: 20050054579
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: May 20, 2002
    Publication date: March 10, 2005
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • Coupling process
    Patent number: 6518434
    Abstract: There is provided a process for the production of a compound of formula I, which process comprises reaction of a compound of formula II, with a compound of formula III, wherein R1, R2, n and R3 have meanings given in the description.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: February 11, 2003
    Assignee: AstraZeneca AB
    Inventors: Jörgen Alvhäll, Daniel Edvardsson, Panagiotis Ioannidis, Magnus Sjögren, Maria Szönyi
  • Crystalline forms
    Publication number: 20030017992
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: May 20, 2002
    Publication date: January 23, 2003
    Applicant: AstraZeneca AB
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • Coupling Process
    Publication number: 20020128452
    Abstract: There is provided a process for the production of a compound of formula I, 1
    Type: Application
    Filed: March 28, 2001
    Publication date: September 12, 2002
    Inventors: Jorgen Alvhall, Daniel Edvardsson, Panagiotis Ioannidis, Magnus Sjogren, Maria Szonyi
  • Crystalline forms
    Patent number: 6440939
    Abstract: There is provided EtO2C—CH2—(R)Cgl—Aze—Pab—OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl—Aze—Pab—OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Grant
    Filed: January 4, 2001
    Date of Patent: August 27, 2002
    Assignee: AstraZeneca AB
    Inventors: Daniel Edvardsson, Lena Hedström, Anita Lundblad, Ursula Pettersson
  • New crystalline forms
    Publication number: 20010023244
    Abstract: There is provided EtO2C—CH2—(R)Cgl—Aze—Pab—OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl—Aze—Pab—OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: January 4, 2001
    Publication date: September 20, 2001
    Applicant: Astra Aktiebolag
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • Crystalline forms
    Patent number: 6225287
    Abstract: There is provided EtO2C—CH2—(R)Cgl—Aze—Pab—OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl—Aze—Pab—OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Grant
    Filed: November 30, 1999
    Date of Patent: May 1, 2001
    Assignee: Astra Aktiebolag
    Inventors: Daniel Edvardsson, Lena Hedström, Anita Lundblad, Ursula Pettersson